London Calling 2026 - Speakers
Speakers
Check out the line up of speakers at London Calling 2026.
A
)
Arianna CerutiLeipzig University, Germany
)
Adela Alcolea-MedinaSynnovis, Guy’s and St Thomas’ NHS Foundation Trust, UK
)
Amy DentonWellcome Sanger Institute, UK
)
Adam GiessGenomics England, UK
)
Alfredo Hidalgo-MirandaNational Institute of Genomic Medicine, Mexico
)
Amanda HughesLonza, The Netherlands
)
Arnfinnur KallsbergFaroese Health Authority, Faroe Islands
)
Alberto MagiUniversity of Florence, Italy
)
Ailsa MacCalmanUniversity of Exeter, UK
)
Anna Maria NiewiadomskaAssociate Director, Segment Marketing — Micro & Infectious Disease, Oxford Nanopore Technologies
)
Alvin NgNanyang Technological University, Singapore
)
Alice OsmastonUniversity College London, UK
)
Ashley PritchardGreat Ormond Street Hospital for Children NHS Foundation Trust, UK
)
André ReisGarvan Institute of Medical Research, Australia
)
Anna RommerskirchenHeinrich-Heine University Dusseldorf, Germany
)
Alessandra RenieriUniversity of Siena, Italy
)
Art RandResearch Scientist, Machine Learning, Oxford Nanopore Technologies
)
C
)
Carla ApazaPeruvian University Cayetano Heredia, Peru
)
Chanatjit CheawsamootChulalongkorn University, Thailand
)
Christoph DieterichHeidelberg University, Germany
)
Cecilia ManciniBambino Gesù Children’s Hospital, Italy
)
Claudia StrafellaSanta Lucia Foundation IRCCS, Italy
)
Catriona WilliamsDevelopment Scientist — Sample Technology, Oxford Nanopore Technologies
D
Dan FordhamHead of Research Solutions, Oxford Nanopore Technologies
)
Danny E. MillerUniversity of Washington, USA
)
David ThomasUniversity of New South Wales, Australia
E
)
Eilis HannonUniversity of Exeter, UK
)
Emma WhiteVP, Marketing, Oxford Nanopore Technologies
)
Eleanor WoodwardNewcastle University, UK
)
Eugenie ‘Charley’ YenUniversity of Massachusetts Amherst, USA & Queen Mary University of London, UK
F
)
Fritz SedlazeckBaylor College of Medicine, USA
)
Francis Van ParysChief Executive Officer, Oxford Nanopore Technologies
G
)
Gabrielle HartleyUniversity of Connecticut, USA
)
Graham HallVP, Sequencing Development, Oxford Nanopore Technologies
)
J
)
Javeria AijazIndus Hospital & Health Network, Pakistan
)
Jaime ChavesSan Francisco State University, USA
)
Jamie MooreJohns Hopkins University, USA
)
Jayne WallaceVP, Nanopore Research and Protein Sequencing, Oxford Nanopore Technologies
K
)
Kimberley BillingsleyNational Institutes of Health, USA
)
Kumeren GovenderUniversity of Oxford, UK
)
Kamil KhanipovThe University of Texas Medical Branch, USA
)
Kylie MontgomeryUK DRI at Cambridge, UK
L
)
Luke Blagdon SnellKing’s College London, UK
)
Lucas Esteban WangePompeu Fabra University, Spain
)
Lakmal JayasingheChief Scientific Officer, Oxford Nanopore Technologies
)
Lennart KesterPrincess Maxima Center for Pediatric Oncology, The Netherlands
Libby SnellSenior Director, RNA & cDNA Sample Technology R&D, Oxford Nanopore Technologies
)
Lara UrbanUniversity of Zurich, Switzerland
M
)
Mariana Bisarro dos ReisBarretos Cancer Hospital, Brazil
)
Max BloomfieldAwanui Laboratories Wellington, New Zealand
)
Mark BruceVP, Sequencing Methods Research, Oxford Nanopore Technologies
)
Mike ClarkThe University of Melbourne, Australia
)
Monika CechovaMasaryk University, Czechia
)
Mae DolendoSt. Jude Global Asia Pacific, Philippines
)
Mikhail KolmogorovNational Cancer Institute, USA
)
Madeline PageUniversity of Kentucky, USA
)
Min Seon ParkUniversity of Washington, USA
)
Mayur PariharTata Medical Center, India
)
Maria Reyes Capilla-GuerraDana-Farber Cancer Institute, USA
)
Marta RudziteBioinformatics Software Developer, Oxford Nanopore Technologies
)
Macey SlotaUniversity of California, San Francisco, USA
)
Mike VellaVP, Machine Learning, Oxford Nanopore Technologies
N
)
Natalia GarciaBioinformatics Software Developer, Oxford Nanopore Technologies
)
Ni-Chung LeeNational Taiwan University Hospital, Taiwan
R
)
Roland ArnoldUniversity of Birmingham, UK
)
Robert A. EdwardsFlinders University, Australia
)
Richard CristUniversity of Pennsylvania, USA
)
Rebecca DeaneAutomation Manager, Oxford Nanopore Technologies
)
Rowan HowellGenomics England, UK
)
Rebecca StubbsSenior Bioinformatician, Commercial Applications, Oxford Nanopore Technologies
)
Rhys WhiteInstitute of Environmental Science and Research, New Zealand
)
Roy WilliamsAspen Neuroscience, USA
S
Simon DunbarManager, Strategic Product Management, Oxford Nanopore Technologies
)
Sophie EhresmannUdeM & IRCM, Canada
)
Sandy FongSickKids Research Institute, Canada
)
Stefan Hardy LungInstitute of Virology Innsbruck, Austria
)
Sissel JuulVP, Applications, Oxford Nanopore Technologies
)
Sebastian LunkeVictorian Clinical Genetics Services, Australia
)
Sefi PrawerThe University of Melbourne, Australia
)
Steven VerbruggenOHMX.bio, Belgium
)
)
)
)
)
Oxford Nanopore Technologies products are RUO. Products labelled/branded as Oxford Nanopore Diagnostics may be RUO or may be regulated as in-vitro diagnostic devices in some jurisdictions, please check individual product labelling. Oxford Nanopore Technologies present the materials of third parties within the user community acknowledging that those materials belong to and are the true statements and representations of those third parties. Oxford Nanopore Technologies make no endorsements of the materials shown and the statements made.
